Pharma Firms Switch Gears from Response to Transformation

The crisis has triggered the need for meaningful partnerships within pharma to speed up R&D and become future ready  

Pharmaceuticals firms are facing disruptions across the value chain – with existing clinical trials, manufacturing operations, supply chain, and commercial operations - that may have a profound and lasting impact on some of their business models and operations going forward.